BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19141600)

  • 1. Endocrine-immune-paracrine interactions in prostate cells as targeted by phytomedicines.
    Gray NE; Liu X; Choi R; Blackman MR; Arnold JT
    Cancer Prev Res (Phila); 2009 Feb; 2(2):134-42. PubMed ID: 19141600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human prostate stromal cells stimulate increased PSA production in DHEA-treated prostate cancer epithelial cells.
    Arnold JT; Gray NE; Jacobowitz K; Viswanathan L; Cheung PW; McFann KK; Le H; Blackman MR
    J Steroid Biochem Mol Biol; 2008 Sep; 111(3-5):240-6. PubMed ID: 18621129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor β1 increase of hydroxysteroid dehydrogenase proteins is partly suppressed by red clover isoflavones in human primary prostate cancer-derived stromal cells.
    Liu X; Piao YS; Arnold JT
    Carcinogenesis; 2011 Nov; 32(11):1648-54. PubMed ID: 21914638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EPI bioassay identifies natural compounds with estrogenic activity that are potent inhibitors of androgenic pathways in human prostate stromal and epithelial cells.
    Vollmer G; Helle J; Amri H; Liu X; Arnold JT
    J Steroid Biochem Mol Biol; 2012 Apr; 129(3-5):153-62. PubMed ID: 22207083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGFβ1 alters androgenic metabolites and hydroxysteroid dehydrogenase enzyme expression in human prostate reactive stromal primary cells: Is steroid metabolism altered by prostate reactive stromal microenvironment?
    Piao YS; Wiesenfeld P; Sprando R; Arnold JT
    J Steroid Biochem Mol Biol; 2013 Nov; 138():206-13. PubMed ID: 23770322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor or estrogen receptor-beta blockade alters DHEA-, DHT-, and E(2)-induced proliferation and PSA production in human prostate cancer cells.
    Arnold JT; Liu X; Allen JD; Le H; McFann KK; Blackman MR
    Prostate; 2007 Aug; 67(11):1152-62. PubMed ID: 17503469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT; Le H; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DHT and testosterone, but not DHEA or E2, differentially modulate IGF-I, IGFBP-2, and IGFBP-3 in human prostatic stromal cells.
    Le H; Arnold JT; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E952-60. PubMed ID: 16368782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer stromal cells and LNCaP cells coordinately activate the androgen receptor through synthesis of testosterone and dihydrotestosterone from dehydroepiandrosterone.
    Mizokami A; Koh E; Izumi K; Narimoto K; Takeda M; Honma S; Dai J; Keller ET; Namiki M
    Endocr Relat Cancer; 2009 Dec; 16(4):1139-55. PubMed ID: 19608712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental and hormonal regulation of transforming growth factor-beta1 (TGFbeta1), -2, and -3 gene expression in isolated prostatic epithelial and stromal cells: epidermal growth factor and TGFbeta interactions.
    Itoh N; Patel U; Cupp AS; Skinner MK
    Endocrinology; 1998 Mar; 139(3):1378-88. PubMed ID: 9492075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dehydroepiandrosterone-induced proliferation of prostatic epithelial cell is mediated by NFKB via PI3K/AKT signaling pathway.
    Sun HZ; Yang TW; Zang WJ; Wu SF
    J Endocrinol; 2010 Mar; 204(3):311-8. PubMed ID: 20007738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DHEA metabolism in prostate: For better or worse?
    Arnold JT
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):83-8. PubMed ID: 19013497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: roles of ERK/MAP kinase.
    Shigemura K; Isotani S; Wang R; Fujisawa M; Gotoh A; Marshall FF; Zhau HE; Chung LW
    Prostate; 2009 Jun; 69(9):949-55. PubMed ID: 19274665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor binding protein-3 (IGFBP-3) in the prostate and in prostate cancer: local production, distribution and secretion pattern indicate a role in stromal-epithelial interaction.
    Massoner P; Haag P; Seifarth C; Jurgeit A; Rogatsch H; Doppler W; Bartsch G; Klocker H
    Prostate; 2008 Aug; 68(11):1165-78. PubMed ID: 18459102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lycopene inhibits IGF-I signal transduction and growth in normal prostate epithelial cells by decreasing DHT-modulated IGF-I production in co-cultured reactive stromal cells.
    Liu X; Allen JD; Arnold JT; Blackman MR
    Carcinogenesis; 2008 Apr; 29(4):816-23. PubMed ID: 18283040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen-induced PSA expression requires not only activation of AR but also endogenous IGF-I or IGF-I/PI3K/Akt signaling in human prostate cancer epithelial cells.
    Liu X; Choi RY; Jawad SM; Arnold JT
    Prostate; 2011 May; 71(7):766-77. PubMed ID: 21031436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of DHEA and DHT on gene expression in human LNCaP prostate cancer cells.
    Steele VE; Arnold JT; Lei H; Izmirlian G; Blackman MR
    Anticancer Res; 2006; 26(5A):3205-15. PubMed ID: 17094431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta1 induces nuclear to cytoplasmic distribution of androgen receptor and inhibits androgen response in prostate smooth muscle cells.
    Gerdes MJ; Dang TD; Larsen M; Rowley DR
    Endocrinology; 1998 Aug; 139(8):3569-77. PubMed ID: 9681509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity.
    Placencio VR; Sharif-Afshar AR; Li X; Huang H; Uwamariya C; Neilson EG; Shen MM; Matusik RJ; Hayward SW; Bhowmick NA
    Cancer Res; 2008 Jun; 68(12):4709-18. PubMed ID: 18559517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of apoptosis in low to moderate-grade human prostate carcinoma by red clover-derived dietary isoflavones.
    Jarred RA; Keikha M; Dowling C; McPherson SJ; Clare AM; Husband AJ; Pedersen JS; Frydenberg M; Risbridger GP
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1689-96. PubMed ID: 12496063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.